No Results
"We are currently gathering more data to assess the safety of nucala.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
NUCALA is a prescription maintenance treatment for patients 12 years and older with severe asthma. NUCALA is not used for sudden breathing problems. Learn more.
Traffic rank of nucala.com, compared to all other sites
↑ 399K+
United States
Website ranking is crucial for evaluating nucala.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, nucala.com's global ranking has increased from 852,291 to 452,942.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to nucala.com based on traffic, content and site structure.
Allergylosangeles alternatives
The American Partnership for Eosinophilic Disorders is a non-profit advocacy organization for those living with eosinophilic related disorders.
Apfed alternatives
FASENRA is an add-on maintenance treatment for patients 12 and older who are diagnosed with severe eosinophilic asthma. Find out more about FASENRA and see if it is the right treatment for you.
Fasenra alternatives
Learn more about Fasenra® (benralizumab) for treatment of eosinophilic asthma in patients with severe asthma. Fasenra® is for patients 12 years or older with severe eosinophilic asthma.
Fasenrahcp alternatives
The Access 360 program provides personal support to connect patients to affordability programs and streamline access and reimbursement for select AstraZeneca medicines.
Myaccess360 alternatives
Explore NUCALA (mepolizumab) and find more information about this treatment option.
Nucalahcp alternatives
XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma not controlled with ICS and chronic idiopathic urticaria (CIU) in appropriate patients. See full safety & Boxed Warning
Xolair alternatives
Cortizone 10 Anti-Itch Products
Cortizone10 alternatives
MIMS online, search the database of prescription and generic drugs, clinical guidelines and patient advice.
Mims alternatives
Medbase-apotheken alternatives
Check out some of our popular sites.